研究

Y. Kobayashi, Y. Sakao, G. A. Deshpande, T. Fukui, T. Mizuno, H. Kuroda, N. Sakakura, N. Usami, Y. Yatabe and T. Mitsudomi

The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity

T. Mitsudomi

Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations

T. Mitsudomi

Dacomitinib: another option for EGFR-mutant lung cancer?

K. Suda and T. Mitsudomi

Successes and limitations of targeted cancer therapy in lung cancer

K. Suda, H. Mizuuchi, I. Murakami, H. Uramoto, F. Tanaka, K. Sato, T. Takemoto, T. Iwasaki, Y. Sekido, Y. Yatabe and T. Mitsudomi

CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation

K. Suda, H. Mizuuchi, K. Sato, T. Takemoto, T. Iwasaki and T. Mitsudomi

The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor

K. Suda, K. Sato, H. Mizuuchi, Y. Kobayashi, M. Shimoji, K. Tomizawa, T. Takemoto, T. Iwasaki, M. Sakaguchi and T. Mitsudomi

Recent evidence, advances, and current practices in surgical treatment of lung cancer

K. Suda, K. Sato, S. Shimizu, K. Tomizawa, T. Takemoto, T. Iwasaki, M. Sakaguchi and T. Mitsudomi

Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinoma

K. Tomizawa, N. Usami, K. Fukumoto, N. Sakakura, T. Fukui, S. Ito, S. Hatooka, H. Kuwano, T. Mitsudomi and Y. Sakao

Risk assessment of perioperative mortality after pulmonary resection in patients with primary lung cancer: the 30- or 90-day mortality